Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METHYLPREDNISOLONE Cause Poor venous access? 43 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 43 reports of Poor venous access have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.1% of all adverse event reports for METHYLPREDNISOLONE.

43
Reports of Poor venous access with METHYLPREDNISOLONE
0.1%
of all METHYLPREDNISOLONE reports
3
Deaths
25
Hospitalizations

How Dangerous Is Poor venous access From METHYLPREDNISOLONE?

Of the 43 reports, 3 (7.0%) resulted in death, 25 (58.1%) required hospitalization, and 7 (16.3%) were considered life-threatening.

Is Poor venous access Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 43 reports have been filed with the FAERS database.

What Other Side Effects Does METHYLPREDNISOLONE Cause?

Off label use (10,364) Drug ineffective (9,959) Product use in unapproved indication (4,115) Condition aggravated (3,784) Headache (3,419) Fatigue (3,250) Pyrexia (3,226) Pain (3,165) Nausea (3,105) Pneumonia (3,006)

What Other Drugs Cause Poor venous access?

VEDOLIZUMAB (1,043) INFLIXIMAB (917) INFLIXIMAB-DYYB (782) ECULIZUMAB (555) HUMAN IMMUNOGLOBULIN G (504) NATALIZUMAB (422) RITUXIMAB (299) TOCILIZUMAB (287) METHOTREXATE (257) ABATACEPT (249)

Which METHYLPREDNISOLONE Alternatives Have Lower Poor venous access Risk?

METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE METHYLPREDNISOLONE vs METILDIGOXIN METHYLPREDNISOLONE vs METOCLOPRAMIDE METHYLPREDNISOLONE vs METOLAZONE

Related Pages

METHYLPREDNISOLONE Full Profile All Poor venous access Reports All Drugs Causing Poor venous access METHYLPREDNISOLONE Demographics